Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis

<p>Muscle Specific Kinase myasthenia gravis (MuSK-MG) is an autoimmune disease that impairs neuromuscular transmission leading to muscle fatigability. No targeted medications are currently available, and non-specific immunotherapies are required. MuSK initiates a phosphorylation cascade regula...

Descripció completa

Dades bibliogràfiques
Autor principal: Cao, M
Altres autors: Beeson, D
Format: Thesis
Idioma:English
Publicat: 2021
Matèries: